Results 251 to 260 of about 76,601 (295)

Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy

open access: yesAllergy, EarlyView.
Ritlecitinib modulated Type I/II immunity genes (CCL5, CD8A, GZMB, CCL13, CCL18, and IL13RA1), MoA genes (JAK3, ITK, and BTK), and upregulated hair keratins, with stronger effects in AAP than AT/AU. Baseline and longitudinal scalp and serum protein changes correlated with hair regrowth and disease improvement.
Li Xi   +6 more
wiley   +1 more source

Brownish-Black Crusts and Erosions all Over the Body. [PDF]

open access: yesIndian Dermatol Online J
Mishra J, Bhoi A, Dash S.
europepmc   +1 more source

A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy

open access: yesBJU International, Volume 135, Issue 4, Page 648-656, April 2025.
Objective To further evaluate a genomic classifier (GC) in a cohort of patients undergoing radical cystectomy (RC), as long non‐coding RNA (lncRNA)‐based genomic profiling has suggested utility in identifying a distinct tumour subgroup corresponding to a favourable prognosis in patients with bladder cancer.
Joep J. de Jong   +14 more
wiley   +1 more source

Familial Disseminated Comedones Without Dyskeratosis: A Case Report. [PDF]

open access: yesCureus
Gutierrez Villarreal IM   +6 more
europepmc   +1 more source

Lichen Planus Follicularis Tumidus. [PDF]

open access: yesAustralas J Dermatol
Oloruntoba AI, Prakash S, Toholka R.
europepmc   +1 more source

Home - About - Disclaimer - Privacy